These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 86997)

  • 21. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
    Shoemaker WJ; Kosten TA; Muly SM
    Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of different benzodiazepines on the experimental morphine abstinence syndrome.
    Maldonado R; Micó JA; Valverde O; Saavedra MC; Leonsegui I; Gibert-Rahola J
    Psychopharmacology (Berl); 1991; 105(2):197-203. PubMed ID: 1686654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking naloxone-precipitated withdrawal in rats and hamsters.
    Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orphanin FQ/nociceptin inhibits morphine withdrawal.
    Kotlińska J; Suder P; Legowska A; Rolka K; Silberring J
    Life Sci; 2000 Jan; 66(8):PL119-23. PubMed ID: 10680585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats.
    Vela G; Fuentes JA; Bonnin A; Fernández-Ruiz J; Ruiz-Gayo M
    Brain Res; 1995 May; 680(1-2):142-7. PubMed ID: 7663970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral alterations produced by chronic naloxone injections.
    Malin DH; Layng MP; Swank P; Baker MJ; Hood JL
    Pharmacol Biochem Behav; 1982 Sep; 17(3):389-92. PubMed ID: 6890681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
    Kosten TA
    Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of lisuride on morphine withdrawal signs in the rat: a dopamine-mimetic effect.
    Ferrari F; Baggio G
    Psychopharmacology (Berl); 1982; 78(4):326-30. PubMed ID: 6818593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice.
    Rodríguez-Arias M; Pinazo J; Miñarro J; Stinus L
    Pharmacol Biochem Behav; 1999 Sep; 64(1):123-30. PubMed ID: 10495006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemic suppression of morphine withdrawal signs in the rat.
    Akunne HC; Soliman KF
    Psychopharmacology (Berl); 1988; 96(1):1-6. PubMed ID: 3147467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.
    Harris AC; Gewirtz JC
    Psychopharmacology (Berl); 2004 Jan; 171(2):140-7. PubMed ID: 13680079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
    Cook CD; Barrett AC; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):93-104. PubMed ID: 11041321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by adenosine analogs of opiate withdrawal effects.
    Tucker JF; Plant NT; von Uexküll A; Collier HO
    NIDA Res Monogr; 1984 Mar; 49():85-91. PubMed ID: 6090921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.
    Manwell LA; Mallet PE
    Psychopharmacology (Berl); 2015 May; 232(9):1655-65. PubMed ID: 25395060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.